Clinical Scorecard: Cataract Surgeons Gain a New Lens Tool
At a Glance
| Category | Detail |
|---|---|
| Condition | Cataract-related vision loss and presbyopia |
| Key Mechanisms | Extended depth of focus intraocular lens designed to improve distance and intermediate vision while providing some near vision capability. |
| Target Population | Adult patients undergoing cataract surgery, including those with preoperative corneal astigmatism. |
| Care Setting | Cataract surgery clinics and ophthalmology practices. |
Key Highlights
- TECNIS PureSee IOL is FDA-approved for cataract surgery.
- Maintains contrast sensitivity comparable to aspheric monofocal IOLs.
- 97% of patients reported no bothersome visual disturbances post-implantation.
- Improves intermediate visual acuity while maintaining distance visual acuity.
- A toric version is available for patients with corneal astigmatism.
Guideline-Based Recommendations
Diagnosis
- Evaluate cataract severity and impact on daily activities.
Management
- Consider TECNIS PureSee IOL for patients with cataracts and presbyopia.
Monitoring & Follow-up
- Assess visual outcomes and patient satisfaction post-implantation.
Risks
- Monitor for potential visual disturbances such as halos or glare.
Patient & Prescribing Data
Adults with cataracts and presbyopia, including those with astigmatism.
TECNIS PureSee IOL offers a balance of distance, intermediate, and some near vision capabilities.
Clinical Best Practices
- Ensure thorough preoperative assessment of visual needs.
- Discuss potential outcomes and risks with patients prior to surgery.
- Utilize the TECNIS PureSee IOL for patients seeking improved intermediate vision.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
